Quick Answer
QIAGEN N.V. reported Long-Term Debt of $1.65 billion for fiscal year 2025.
QIAGEN N.V. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2025 | $1.65B | +97.0% |
| 2024 | $839.66M | -8.9% |
| 2023 | $921.82M | -37.4% |
| 2022 | $1.47B | +34.5% |
| 2021 | $1.09B | -41.8% |
| 2020 | $1.88B | +32.3% |
| 2019 | $1.42B | -15.0% |
| 2018 | $1.67B | -5.0% |
| 2017 | $1.76B | +64.8% |
| 2016 | $1.07B | +1.7% |
| 2015 | $1.05B | +0.8% |
| 2014 | $1.04B | +23.2% |
| 2013 | $845.28M | -0.1% |
| 2012 | $846.04M | +89.7% |
| 2011 | $446.00M | -44.1% |
| 2010 | $797.17M | -8.4% |
| 2009 | $870.00M | — |
- QIAGEN N.V. showed an increase of +97.0% in Long-Term Debt compared to the prior fiscal year.
- Over the 2009–2025 period, QIAGEN N.V.’s long-term debt has grown by 90.2% (from $870.00 million to $1.65 billion).
- The most recent figure is from QIAGEN N.V.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: